EPSRC Centre for Doctoral Training in Emergent Macromolecular Therapies (EMT): A National CDT linked to an EPSRC Centre for Innovative Manufacturing

In the following table, contact information relevant to the page. The first column is for visual reference only. Data is in the right column.

Organisation: University College London
Tags: CDT, University College London
Related theme: Manufacturing the future

This EPSRC CDT will deliver a national capability for training the next generation of highly skilled future leaders and researchers for the biopharmaceutical manufacturing sector. Novel biopharmaceutical therapies are rapidly emerging with promising efficacy for currently intractable conditions, but they are also challenging to manufacture. The PhD students will be capable of translating new scientific advances and manufacturing technologies to enable their safe production at affordable costs. They will explore new process engineering, modelling, analysis, formulation and drug delivery techniques, as well as novel therapies, as they emerge from the international science and engineering community.